Naresh Sah
Texas Tech Univeristy Health Sciences Center, United States
- Publications: 20
- Citations: 120
- Keywords: Cancer Therapeutics, Drug Resistance, Molecular Oncology, Nanomedicine, Pharmacogenomics, Tumor Micro-environment, DNA repair, Immunotherapy, Molecular Oncology, Targeted Therapy, Experiemental Therapeutics
Short Bio
- Dr. Naresh Sah holds a Doctor of Pharmacy (Pharm.D.) and is currently a Ph.D. candidate in Biomedical Sciences at Texas Tech University Health Sciences Center. His research lies at the intersection of cancer therapeutics, drug resistance, and translational oncology, with a particular focus on innovative drug delivery systems, nanomedicine, and biomarker-driven treatment strategies. Dr. Sah has authored more than 20 peer-reviewed publications and has been invited to review over 60 manuscripts for high-impact journals including Scientific Reports (Nature), Frontiers in Pharmacology, Cancer Reports (Wiley), and Elsevier Oncology. He serves as a Review Editor for multiple journals and contributes regularly as a peer reviewer for international conferences such as AACR and AAPS. With a multidisciplinary background encompassing molecular pharmacology, pharmacogenomics, and biomedical informatics, Dr. Sah is committed to advancing precision medicine and improving therapeutic outcomes for cancer patients through rigorous scientific inquiry and editorial contribution.
